Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06423326
Status:
RECRUITING
Last Update Posted:
2024-05-21
First Post:
2024-04-10
Brief Title:
Gemcitabine Cisplatin and Nab-Paclitaxel As Neoadjuvant Treatment for Patients with Resectable or Borderline Resectable Pancreatic Cancer
Sponsor:
Organization:
Emory University